Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.70NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.43NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.559NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.406NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.69NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.26NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
ER.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.640NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
BA.1.1.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.7 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.460NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.262NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBUNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.351.5 (Beta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FZ.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.9.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBC.1.6.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.4.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.11 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.428NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.355NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.34.1.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.71 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.33.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.52NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.465NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.33NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.2.5 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XFNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.115NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.127.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.88NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AP.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AK.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.98.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.13.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HK.34.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.124.1.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.203NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.8.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.237NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBNNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBJ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.356NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.462NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.29NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.147NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used